Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Express Scripts
Teva
Federal Trade Commission
Moodys
Merck

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 7,482,327

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,482,327
Title:Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules
Abstract: The present invention provides use of soluble CTLA4 mutant molecules which bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or non-mutated CTLA4Ig in the treatment of immune disorders associated with graft transplantation.
Inventor(s): Hagerty; David (Pennington, NJ), Rusnak; James (Newtown, PA)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:11/399,666
Patent Claims:see list of patent claims

Details for Patent 7,482,327

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Bristol-Myers Squibb Company (Princeton, NJ) 2025-04-06 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12 ➤ Sign Up Bristol-Myers Squibb Company (Princeton, NJ) 2025-04-06 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12 ➤ Sign Up Bristol-Myers Squibb Company (Princeton, NJ) 2025-04-06 RX search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Sign Up Bristol-Myers Squibb Company (Princeton, NJ) 2025-04-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
McKesson
Boehringer Ingelheim
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.